Protalix BioTherapeutics, Inc.PLX was a big mover last session, as its shares rose almost 9% on the day. The upside was driven by the news of Pfizer PFE building its position in Protalix. This also led to far more shares changing hands than in a normal session. Yesterday's rally breaks the trend for the company since Oct 12, as the stock is now trading above the volatile price range of $0.98 to $1.11.
Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday's jump can turn into more strength down the road.
Protalix BioTherapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report